New FDA-approved screening options make colorectal cancer detection easier than ever, with 91% survival rates when caught ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

March is National Colorectal Cancer Awareness Month, a reminder that taking care of ourselves isn’t a weakness, but it’s a ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

Colorectal cancer now leads cancer deaths in adults under 50, with cases rising since 1995. Learn when to start screening and recognize key symptoms to protect yourself.